Skip to content
InsideEdge
Investors / filer profile

Track record

What happened ~6 months after each disclosed buy

+113.8%avg per buy, ~6 months on+9.7%S&P 500 avg, same spans
ARQT · 2025-06-04 · +131.8% (S&P +12.2%)ARQT · 2025-06-05 · +127.5% (S&P +13.8%)ARQT · 2025-06-13 · +132.0% (S&P +14.6%)MBX · 2025-09-26 · +63.8% (S&P -2.0%)
2025-06-042025-09-26
Each dot: one completed buy’s ~6-month outcome, equal weight per buy · dashed: S&P 500 over the same spans · hover a dot for detail
4 of 4
buys higher ~6mo later
+131.8%
median outcome
+13.8%
S&P 500 median, same spans

1 buy still inside the ~6-month window — not scored yet.

Disclosed positions

Estimated from their latest filings — positions may have changed since

$383.70M
combined est. value

Activity

Open-market buy & sell volume

BuySell
0$6.0M$12.1M2025 · bought $12.1M · sold $020252026 · bought $9.0M · sold $02026
Total +$21.06M bought

All filings on record

Every Form 4 transaction we track for this filer

ARQTGrant
2026-06-05 · Arcutis Biotherapeutics, Inc.
5,778
—
MIRMBuy
2026-01-23 · Mirum Pharmaceuticals, Inc.
$9.00M
in progress
MIRMOther
2026-01-23 · Mirum Pharmaceuticals, Inc.
159,277
—
MBXBuy
2025-09-26 · MBX Biosciences, Inc.
$12.00M
+63.8%
HLVXGrant
2025-06-23 · HilleVax, Inc.
17,199
—
ARQTBuy
2025-06-13 · Arcutis Biotherapeutics, Inc.
$34.6K
+132.0%
ARQTGrant
2025-06-12 · Arcutis Biotherapeutics, Inc.
7,609
—
ARQTBuy
2025-06-05 · Arcutis Biotherapeutics, Inc.
$5.1K
+127.5%
ARQTBuy
2025-06-04 · Arcutis Biotherapeutics, Inc.
$25.2K
+131.8%
MIRMExercise
2025-05-29 · Mirum Pharmaceuticals, Inc.
5,703
—

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.